Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2005-12-06
2005-12-06
Riley, Jezia (Department: 1637)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023100, C536S024100, C536S024300, C536S024330
Reexamination Certificate
active
06972328
ABSTRACT:
The invention provides compositions and methods for improved hybridization analysis utilizing DNA, RNA, PNA and chimeric oligomers in which one or more purine bases are substituted by a pyrazolo[5,4-d]pyrimidine or by a 7-deazapurine purine analogue. Reduced self-aggregation and reduced fluorescence quenching are obtained when the oligomers are used in various methods involving hybridization. Methods of synthesis, as well as novel synthetic precursors, are also provided.
REFERENCES:
patent: 5176996 (1993-01-01), Hogan et al.
patent: 5210015 (1993-05-01), Gelfand et al.
patent: 5419966 (1995-05-01), Reed et al.
patent: 5422251 (1995-06-01), Fresco
patent: 5480980 (1996-01-01), Seela
patent: 5492806 (1996-02-01), Drmanac et al.
patent: 5512667 (1996-04-01), Reed et al.
patent: 5525464 (1996-06-01), Drmanac et al.
patent: 5539082 (1996-07-01), Nielsen et al.
patent: 5556752 (1996-09-01), Lockhart et al.
patent: 5594121 (1997-01-01), Froehler et al.
patent: 5714331 (1998-02-01), Buchardt et al.
patent: 5736336 (1998-04-01), Buchardt et al.
patent: 5766855 (1998-06-01), Buchardt et al.
patent: 5773571 (1998-06-01), Nielsen et al.
patent: 5801155 (1998-09-01), Kutyavin et al.
patent: 5824796 (1998-10-01), Petrie et al.
patent: 5844106 (1998-12-01), Seela et al.
patent: 6127121 (2000-10-01), Meyer et al.
patent: 6156501 (2000-12-01), McGall et al.
patent: 0 286 028 (1988-10-01), None
patent: WO 90/14353 (1990-11-01), None
patent: WO 92/10588 (1992-06-01), None
patent: WO 92/20702 (1992-11-01), None
patent: WO 96/17957 (1996-06-01), None
patent: WO 96/32496 (1996-10-01), None
patent: WO 96/32496 (1996-10-01), None
patent: WO 98/49180 (1998-11-01), None
patent: WO 99/40226 (1999-08-01), None
patent: WO 99/51621 (1999-10-01), None
patent: WO 99/51775 (1999-10-01), None
Ausubel et al. (1987 and annual updates).Current Protocols in Molecular Biology, John Wiley & Sons, Inc., pp. iii-xii (Table of Contents).
Belousov et al. (1998). “Triplex targeting of a native gene in permeabilized intact cells: Covalent modification of the gene for the chemokine receptor CCR5,”Nucl. Acids Res., 26(5): 1324-1328.
Bicket et al. (Sep. 6, 1994). “A high throughout flourogenic substrate for stromelysin (MMP-3),”Ann. NY Acad. Sci., 732:351-355.
Demidov et al. (Mar. 1995). “Kinetics and mechanism of polyamide (“peptide”) nucleic acid binding to duplex DNA,”Proc. Natl. Acad. Sci., USA 92:2637-2641.
Diederichson et al.European Journal of Organic Chemistry1998, pp. 827-835.
During et al. (Aug. 1999). “PNAs breach the blood-brain barrier,”Nature Biotechnol, 17:753-754.
Eckstein (ed.). (1991).Oligonucleotides and Analogues: A Practical Approach, IRL Press: Oxford, pp. ix-xvii (Table of Contents).
Efimov et al. (1998). “Synthesis and evaluation of some properties of chimeric oligomers containing PNA and phosphono-PNA residues,”Nucl. Acids. Res. 26(2):566-577.
Egholm. (Jun. 21-23, 1999). “PNA: A DNA mimic with unique properties,” inCambridge Healthtech Institute's Seventh Annual Nucleic Acid-Based Technologies. Wyndham Washington Hotel: Washington, D.C., <http://www.healthtech.com/conference/past_conferences/pcr/pcr .htm> (visited on Dec. 9, 1999), pp. 1 and 10.
Gait (ed.). (1984).Oligonucleotide Synthesis: A Practical Approach. IRL Press: Oxford, pp. vii-xiii (Table of Contents).
Gangamani et al. (1997). “Spermine conjugated peptide nucleic acids (spPNA): UV and flourescence studies ofPNA-DNA hybrids with improved stability,”Biochem. Biophys. Res. Comm. 240:778-782.
Greene et al. (1991). “Reactive charts,” inProtective Groups in Organic Synthesis. Second edition, John Wiley and Sons, Inc: NY., pp. 441-452.
Haugland (ed.). (1996).Handbook of Fluorescent Probes and Research Chemicals. Sixth edition, Molecular Probes, Inc.: Eugene, OR., pp. xii-ix (Table of Contents).
Hawthorne et al. (1997) “Evaluation of some fluorogenic substrates for continuous assay of aminopeptidase P,”Anal. Biochem. 253:13-17.
Koppitz et al. “Formation of Oligonucleotide-PNA-Chimeras by template-directed ligation,”JACS1998, 120, pp. 4563-4569.
Lampe, (1997). “Factors influencing the extent and selectivity of alkylation within triplexes by reactive G/A motif oligonucleotides,”Nucl. Acids Res. 25(20):4123-4131.
Lee et al. (1993). “Allelic discrimination by nick-translation PCR with fluorogenic probes,”Nucl. Acids Res. 21(16):3671-3766.
Lee et al. (Aug. 1999). “Seven-color, homogenyous detection of six PCR products,”Biotechniques27:342-349.
Li et al. (1999). “Design, synthiesis, and spectroscopic properties of peptide-bridged flourescence energy-transfer cassettes,”Bioconj. Chem. 10:241-245.
Livak et al. (1995). “Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization,”PCR Meth. App. 4:357-362.
Lohse, et al. (1997). “Flourescein-Conjugated Lysine Monomers for Solid Phase Synthesis of Flourescent Peptides and PNA Oligomers,”Am. Chem. Soc.
Maniatis et al. (1982).Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, pp. v-x (Table of Contents).
Matayoshi et al. (Feb. 1990). “Novel flourogenic substrates for assaying retroviral proteases by resonance energy transfer,”Science247:954-958.
Murchie et al. (1994). “Tetraplex folding of telomere sequences and the inclusion of adenine bases,”EMBO J. 13(4):993-1001.
Murchie, et al. (1991). “Retinoblastoma suspectibility genes contain 5′ sequences with a high propensity to form guanine-tetrad structures,”Nucl. Acid Res. 20 (1):49-53.
Nielsen et al. (Dec. 1991). “Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide,”Science254:1497-1500.
Ogilvie et al. (Aug. 1988). “Total chemical synthesis of a 77-nucleotide-long RNA sequence having methionine-acceptance activity,”Proc. Natl. Acad Sci. USA 85:5764-5768.
Peyman et al. (1997). “Phona-PNA co-oligomers: Nucleic acid mimetics with interesting properties,”Angew. Chem. Int. Ed Engl. 36(24):2809-2812.
“PNA design guidelines,” Perspective Design Guidelines, at <http://www.resgen.comlperseptivedesign.html> (visited on Oct. 19, 1999), 3 pages total.
Ramzaeva, N., C. Mittelbach and F. Seela. Nucleosides & Nucleotides, 18 (6&7), 1439-1440 (1999). 7-Deaza-2′-deoxyguanosines functionalized with 7-(ω-aminoalk-1-ynyl) residues.
Rothman et al. (1999), “A new generation of flourescent chemosensors demonstrate improved analyte detection sensitivity and photobleaching resistance,”Bioorg. Med Chem. Lett, 9:509-512.
Sambrook et al. (1989).Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor Laboratory Press, pp. xi-xxxviii (Table 0 Contents).
Seela et al.} 1985). “Solid-phase synthesis of the self-complimentary hexamer d(c70pCpcOpCpc70pC) via the 0-3′-phosphoramidite of7-deaza-2′-deoxyguanosine,”Nucl. Acids Res. 13(3):911-926.
Seela et al. (1985). “Synthesis of the p-D-deoxyribofuranoside of 6-amino-1 Hpyrazolo(3,4d):.pyrimidin-4(5H)-one-A new isoster of 2′-deoxyguanosine,”Heterocycles23:2521-2524.
Seela et al. (1986). “Palindromic oligonucleotides containing 7-deaza-2′ -deoxyguanosine: Solid phase sythesis of d[(P )00* AA TTCC] octamers and recognition by the endodeoxyribonuclease EcoRI,”Nucl. Acids Res. 14(5):2319-2332.
Seela et al. (1987). “Palindromic octa-and dodecanucleotides containing 2′ -deoxytubercidin: Synthesis, hairpin formation, and recognition by the endodeoxyribonuclease EcoRI,”Biochem. 26(8):2232-2238.
Seela et al. (1988). “131. 8-aza-7-deaza-2′ -deoxyguanosine: Phosphoramidite synthesis and properties ofoctanucleotides,”Helv. Chem. Acta. 71:1191-1198.
Seela et al. (1998). &#x
Dempcy Robert O.
Gall Alexander A.
Kutyavin Igor V.
Vermeulen Nicolaas M. J.
Epoch Biosciences, Inc.
Riley Jezia
Townsend and Townsend / and Crew LLP
LandOfFree
Non-aggregating non-quenching oligomer comprising nucelotide... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-aggregating non-quenching oligomer comprising nucelotide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-aggregating non-quenching oligomer comprising nucelotide... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3518638